These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2973371)

  • 1. Inhibition of rat ovarian [3H]thymidine uptake by luteinizing hormone-releasing hormone agonists: a possible mechanism for preventing damage by cytotoxic agents.
    Ataya KM; Palmer KC; Blacker CM; Moghissi KS; Mohammad SH
    Cancer Res; 1988 Dec; 48(24 Pt 1):7252-6. PubMed ID: 2973371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
    Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression.
    Gordon A; Garrido-Gracia JC; Aguilar R; Bellido C; Velasco JA; Millan Y; Tena-Sempere M; Martín de Las Mulas J; Sánchez-Criado JE
    J Endocrinol; 2008 Mar; 196(3):583-92. PubMed ID: 18310454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus.
    Sakamoto S; Tajima M; Sawaki K; Suzuki S; Kudo H; Sassa S; Kuwa K; Sugiura Y; Kasahara N; Nagasawa H
    In Vivo; 1993; 7(1):13-6. PubMed ID: 8504203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GnRH agonists on the thymus in female rats.
    Ataya KM; Sakr W; Blacker CM; Mutchnick MG; Latif ZA
    Acta Endocrinol (Copenh); 1989 Dec; 121(6):833-40. PubMed ID: 2532849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The follicle-deplete mouse ovary produces androgen.
    Mayer LP; Devine PJ; Dyer CA; Hoyer PB
    Biol Reprod; 2004 Jul; 71(1):130-8. PubMed ID: 14998904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the production of a growth-inhibitory factor by human granulosa-luteal cells.
    Dain LB; Bley MA; Barańao JL; Tesone M
    Mol Reprod Dev; 1993 Oct; 36(2):159-63. PubMed ID: 8257565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ionizing radiation and pretreatment with [D-Leu6,des-Gly10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles.
    Jarrell J; YoungLai EV; McMahon A; Barr R; O'Connell G; Belbeck L
    Cancer Res; 1987 Oct; 47(19):5005-8. PubMed ID: 3113726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex.
    Holdaway IM; Parr CE; France J
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):164-5. PubMed ID: 1834050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible increase in energy deposition following castration induced by a gonadotropin releasing hormone agonist.
    Richard D; DeKoninck P; Lemay A; Rivest S
    Int J Obes; 1991 Feb; 15(2):155-61. PubMed ID: 1904053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
    Goulding A; Gold E; Feng W
    Bone Miner; 1992 Aug; 18(2):143-52. PubMed ID: 1525595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.
    Thomas EJ; Jenkins J; Lenton EA; Cooke ID
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1407-8. PubMed ID: 2948607
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
    Nicholson RI; Kéri G
    Tumour Biol; 1992; 13(1-2):44-50. PubMed ID: 1534181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonist inhibits physiologic ovarian follicular loss in rats.
    Ataya K; Tadros M; Ramahi A
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):55-60. PubMed ID: 2525857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of LHRH agonist, Zoladex, on ovarian histology.
    Williamson K; Robertson JF; Ellis IO; Elston CW; Nicholson RI; Blamey RW
    Br J Surg; 1988 Jun; 75(6):595-6. PubMed ID: 2969269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of reproductive status on vasopressin release in the rat.
    Forsling ML; Kelestimur H; Windle R
    J Endocrinol; 1991 Sep; 130(3):387-93. PubMed ID: 1834756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.
    Martikainen H; Penttinen J; Huhtaniemi I; Kauppila A
    Gynecol Oncol; 1989 Dec; 35(3):406-8. PubMed ID: 2532171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.